Effect of diltiazem on myocardial infarct size estimated by enzyme release, serial thallium-201 single-photon emission computed tomography and radionuclide angiography

The American Journal of Cardiology

Volumn 61, Issue 15, 1988, Pages 1172-1177

  Zannad, Faiez ^a   Amor, Max ^a   Karcher, Gilles ^a   Maurin, Philippe ^a   Ethevenot, Gerard ^a   Sebag, Claude ^a   Bertrand, Alain ^a   Pernot, Claude ^a   Gilgenkrantz, Jean Marie ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM; HEART ENZYME; RADIOISOTOPE; THALLIUM 201;

ANGIOGRAPHY; COMPUTER ANALYSIS; HEART INFARCTION SIZE; HEART SINOATRIAL BLOCK; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

CLINICAL TRIALS; COMPARATIVE STUDY; CREATINE KINASE; DILTIAZEM; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; ENZYME TESTS; HUMAN; ISOENZYMES; MONITORING, PHYSIOLOGIC; MYOCARDIAL INFARCTION; RADIONUCLIDE ANGIOGRAPHY; RANDOM ALLOCATION; TECHNETIUM; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0023875347     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(88)91149-6     Document Type: Article

References (25)

1. The reduction of infarct size. An idea whose time (for testing) has come
2. Reduction of infarct size. An attractive concept: useful or possible in humans?
3. Isosorbide dinitrate sublingual therapy for inferior myocardial infarction: randomized trial to assess infarct size limitation
4. Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the norvegian nifedipine multicenter trial
5. Effects of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs
6. Diltiazem pretreatment reduces experimental myocardial infarct size in rat
7. The effect of two different diltiazem treatments on infarct size in ischemic reperfused porcine hearts
8. Hemodynamic effects of intravenous diltiazem in patients with recent myocardial infarction
9. Hemodynamic effects of calcium ion antagonists after acute myocardial infarction
10. Estimation of infarct size in man and its relation to prognosis
11. Quantitaton of diltiazem and desacetyl-diltiazem in dog plasma by high performance liquid chromatography
12. Estimation of acute myocardial infarct size in man by serum MBCK measurements
13. Creatine kinase release in acute myocardial infarction: correlation with clinical, electrocardiographic and pathological findings
14. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity
15. The creatine kinase curve area and peak creatine kinase after acute myocardial infarction: usefulness and limitation
16. Correlation of radionuclide estimate infarction size and release of creatine kinase MB in man
17. Estimation of infarct size by myocardial emission computed tomography with thallium 201 and its relations to creatine kinase-MB release after myocardial infarction in man
18. Improved detection of myocardial infarction by emission computed tomography with thallium 201 relation to infarct size
19. Effects of diltiazem on experimental myocardial ischemia and on left ventricular performance
20. Differential effects of verapamil and diltiazem on regional blood flow and function in the canine normal and ischemic myocardium
21. Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo controlled comparison
22. Reduction of creatine kinase and creatine kinase MB indexes of infarct size by intravenous verapamil
23. Effects of verapamil on enzyme release after early intravenous administration of acute myocardial infarction: double-blind randomized trial
24. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial
25. Diltiazem: a review of its pharmacological properties and therapeutic efficacy